Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000930413-11-001216)

Filing Details

Accession Number:: 0000930413-11-001216
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-24 18:32:09
Reporting Period:: 2011-02-22

Filing Date:: 2011-02-24
Accepted Time:: 2011-02-24 18:32:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
727510	Enzon Pharmaceuticals Inc	ENZN	Biological Products, (No Disgnostic Substances) (2836)	222372868

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1007931	Robert Lebuhn	C/O Enzon Pharmaceuticals, Inc. 685 Route 202/206 Bridgewater, NJ 08807		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-02-22	10,000	$10.88	96,519	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the weighted average price for sales of the shares. The shares were sold at prices ranging from $10.87 per share to $10.9001 per share.
The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased or sold at each separate price.